Categories: News

Due to COVID-19, Pain Therapeutics Conference Will be Accessed Remotely

SMi Group reports: Pain Therapeutics conference will reconvene on 11th and 12 May by remote access.

London, United Kingdom, April 04, 2020 –(PR.com)– Regarding concerns over COVID-19 SMi’s 20th Annual Pain Therapeutics conference will return on the 11th and 12th May 2020 via remote access only. The two-day conference will provide delegates the chance to explore all areas of pain therapeutics, such as pain treatment highlighting clinical success to date as well as evaluating the potential of drug candidates in the pipelines of the top pharmaceutical organisations.

The conference will look to discover novel drug targets for pain management, diverse research strategies and novel pre-clinical models and discuss how leading pharma companies are utilising these to reduce pain across a range of medical conditions.

For those interested, registration is available online at www.pain-therapeutics.co.uk/PR4

Featured topics include:
• Facilitating Pain Research via Biomarkers Discovery
• Novel Drug Targets on the Horizon
• Targets with clinical evidence provided by serendipity
• Learn from Opioid crisis
• The Impact of Chronic Pain – The Patients Perspective
• Migraine Treatment
• The Grunenthal approach to tackle the underlying pathophysiology’s of pain
• Limitation of Migraine Treatment
• Learn about DENKI and PL37 MOA

The two-day programme will consist of keynote presentations from leading pharma organisations such as Centrexion Therapeutics, Collegium Pharma, Mundipharma Research Ltd, Eli Lily, Pain Alliance Ltd, Janssen and more.

Discover the latest innovations in analgesic therapies at this conference with the Co-chairs, Kerrie Brady from Centrexion Therapeutics and Michael Scherz from Metys Pharmaceuticals, who will be chairing the two-day conference with remote access only.

The updated programme and speaker line-up can be seen at www.pain-therapeutics.co.uk/PR4

For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk

Pain Therapeutics 2020
Conference: 11th – 12th May 2020
Remote Access Only
www.pain-therapeutics.co.uk/PR4
#SMiPain

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Let’s block ads! (Why?)

Miscw.com

Recent Posts

Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally

Mollie Pearce, star of the UK reality TV show ‘The Traitors’ who was diagnosed with…

6 hours ago

Quality Building Award 2024 Unveils Finalist List

QBA 2024 Announces 35 Finalists Competing for Hong Kong's Highest Honour in the Building Industry…

2 days ago

UXLINK Tops RootData’s Latest X Hot Items List and DappRadar Social Apps List

SINGAPORE - Media OutReach Newswire - 17 May 2024 - UXLINK, the Web3 social platform…

2 days ago

Australia Construction Industry Report 2024: Growth to Slow to 2% in Real-terms this Year Following 9% Growth in 2023 – Forecasts to 2028 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to…

2 days ago

Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast

Three-part podcast interview features The mechanism of action of ANKTIVA® activating NK cells, Killer T…

2 days ago

Wipro Appoints Sanjeev Jain as Chief Operating Officer

EAST BRUNSWICK, N.J. & BENGALURU, India--(BUSINESS WIRE)--$WIPRO #AIprinciples--Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO),…

2 days ago